VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 131 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,400 | -60.4% | 33,600 | -41.5% | 0.00% | -50.0% |
| Q2 2023 | $657,173 | +227.8% | 57,395 | +120.8% | 0.00% | +100.0% |
| Q1 2023 | $200,460 | +1.2% | 26,000 | -22.2% | 0.00% | 0.0% |
| Q2 2022 | $198,000 | -73.1% | 33,427 | -65.3% | 0.00% | -50.0% |
| Q1 2022 | $735,000 | +1212.5% | 96,457 | +616.7% | 0.00% | – |
| Q2 2021 | $56,000 | -96.4% | 13,459 | -95.9% | 0.00% | -100.0% |
| Q1 2021 | $1,540,000 | +53.5% | 326,994 | +354.8% | 0.00% | +33.3% |
| Q4 2019 | $1,003,000 | -23.3% | 71,897 | -5.3% | 0.00% | -25.0% |
| Q3 2019 | $1,307,000 | +0.9% | 75,930 | +59.5% | 0.00% | 0.0% |
| Q2 2019 | $1,295,000 | -2.0% | 47,591 | -66.1% | 0.00% | -20.0% |
| Q4 2018 | $1,321,000 | -18.3% | 140,536 | +64.4% | 0.01% | +25.0% |
| Q3 2018 | $1,617,000 | -51.6% | 85,481 | -50.0% | 0.00% | -60.0% |
| Q2 2018 | $3,338,000 | +939.9% | 170,817 | +898.9% | 0.01% | +900.0% |
| Q1 2018 | $321,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
| Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
| Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
| ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
| Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
| PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
| Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
| Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
| 361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
| Birchview Capital, LP | 30,000 | $516,000 | 0.34% |